CP
PFE icon

Cumberland Partners’s Pfizer PFE Stock Holding History

Cumberland Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.39M Buy
191,855
+61,285
+47% +$1.63M 0.41% 42
2025
Q4 		$3.25M Buy
130,570
+53,970
+70% +$1.36M 0.2% 94
2025
Q3 		$1.95M Hold
76,600
– – 0.13% 107
2025
Q2 		$1.86M Hold
76,600
– – 0.13% 106
2025
Q1 		$1.94M Hold
76,600
– – 0.15% 102
2024
Q4 		$2.03M Buy
+76,600
New +$2.08M 0.14% 103
2022
Q3 		– Sell
-15,610
Closed -$818K – 167
2022
Q2 		$818K Buy
15,610
+900
+6% +$45.9K 0.08% 119
2022
Q1 		$761K Buy
14,710
+4,758
+48% +$247K 0.06% 127
2021
Q4 		$588K Buy
+9,952
New +$493K 0.04% 147
2018
Q3 		– Sell
-6,324
Closed -$218K – 201
2018
Q2 		$218K Buy
+6,324
New +$216K 0.02% 180

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cumberland Partners's PFE Position: Q1 2026 in Review

Cumberland Partners increased its Pfizer (PFE) stake by 47% in Q1 2026, buying an estimated $1.63M and bringing the position to 191,855 shares worth $5.39M. The position accounts for 0.41% of the portfolio, ranked #42.

Cumberland Partners first reported a position in PFE in Q2 2018 and has held it in 10 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cumberland Partners held 191,855 shares of Pfizer worth $5.39M as of Q1 2026.
  • Cumberland Partners bought 61,285 Pfizer shares in Q1 2026, an estimated $1.63M.
  • Pfizer made up 0.41% of Cumberland Partners's portfolio in Q1 2026, its #42 holding.
  • Cumberland Partners first reported a position in Pfizer in Q2 2018 and has held it in 10 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cumberland Partners's 13F filing for Q1 2026, filed 14 May 2026.